All eligible patients will have to consent to the study. The study population will consist of participants aged between 18 and 75 years old in the following cohorts (Healthy individuals, Non-alcoholic steatohepatitis (non-cirrhotic) and compensated Non-alcoholic liver cirrhosis). Each cohort will have 30 patients. There will be an equal number of participants for the healthy control group. In summary, the investigators aim to recruit 30 subject in the patient cohorts and 30 in healthy, totaling a number of 90 in the study